Cart
sales@molnova.com
(-)-vibo-Quercitol
CAS No. 488-76-6
(-)-vibo-Quercitol( —— )
Catalog No. M19340 CAS No. 488-76-6
(-)-vibo-Quercitol is a carbaglycosylamine glycosidase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 81 | In Stock |
|
| 2MG | 62 | In Stock |
|
| 5MG | 102 | In Stock |
|
| 10MG | 150 | In Stock |
|
| 25MG | 255 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(-)-vibo-Quercitol
-
NoteResearch use only, not for human use.
-
Brief Description(-)-vibo-Quercitol is a carbaglycosylamine glycosidase inhibitor.
-
Description(-)-vibo-Quercitol is a carbaglycosylamine glycosidase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number488-76-6
-
Formula Weight164.16
-
Molecular FormulaC6H12O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@@H]1C[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ogawa S., et al. Synthesis of valiolamine and some precursors for bioactive carbaglycosylamines from (-)-vibo-quercitol produced by biogenesis of myo-inositol. J Nat Prod. 2007 Mar;70(3):493-7.
molnova catalog
related products
-
5-Hydroxy-1,7-diphen...
5-Hydroxy-1, 7-diphenyl-6-hepten-3-one has antioxidant activity.
-
A 582941 HCl (848591...
A-582941 is a alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing propertiesA-582941 was found to exhibit high-affinity binding and partial agonism at alpha7 nAChRs, with acceptable pharmacokinetic properties and excellent distribution to the central nervous system (CNS).
-
α-Conotoxin EI
α-Conotoxin EI is a selective nicotinic acetylcholine α1β1γδ receptor (nAChR) antagonist (IC50=187 nM) and an α3β4 receptor inhibitor. α-Conotoxin EI can block muscle and ganglionic receptors.
